IBEX Pharmaceuticals Inc Company
IBEX markets a line of recombinant high-purity proprietary enzymes from Flavobacterium heparinum.
Technology:
Others
Industry:
Telemedicine
Headquarters:
Canada
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership